Dysgeusia (Taste Disorders) Global Clinical Trials Review, H2, 2017

2017-07-28
Price :
Published : Jul-2017
No. of Pages : 45

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H2, 2017” provides an overview of Dysgeusia (Taste Disorders) clinical trials scenario. This report provides top line data relating to the clinical trials on Dysgeusia (Taste Disorders). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Pharm-Olam International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics submissions, data management, biostatistics, pharmacovigilance, rescue studies, project management, import and export licenses, contract negotiation and administration and product registration among others. Pharm-Olam's target therapeutic areas include anti-infectives, cardiology, dermatology, endocrinology, gastroenterology, oncology, respiratory, rheumatology, and others. The company has operations across North America, Western Europe, Central and Eastern Europe, Latin America, Asia and South A......
$250

Novaliq GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a preservative free eye drop product for the relief of discomfort under dry eye syndrome. Novaliq also has products in pipeline for the treatment of glaucoma and other retinal diseases. The company offers its SFA technology as a delivery platform for external co-development cooperations. It licenses its SFA technology to distribution partners who completes registration studies. Novaliq is headquartered in Heidelberg, Germany. Novaliq GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Prof......
$250

Fidia farmaceutici SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint health care with primary emphasis on osteoarthritis; advanced wound care; and aesthetic medicine. It also offers products for other therapeutic areas such as impaired joint function; acute localized pain; herpes labialis; burns and rashes. Fidia operates along with its subsidiaries located in the US, Germany and Kazakhstan. The company works in partnership with pharmaceutical and biomedical companies to commercializes its products worldwide. Fidia is headquartered in Abano Terme, Italy. Fidi......
$250

Immunomic Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Immunomic Therapeutics Inc (ITI) is a biotechnology company that specializes in developing vaccines based on the patented lysosomal associated membrane protein or lamp technology. The company's pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy. It develops vaccine therapies by incorporating the genetic sequence for LAMP protein as part of the DNA vaccine. ITI's product development pipeline also focuses on the allergy product area for internal development including products for global cedar, juniper, cypress allergy, peanut allergy and flea allergy in dogs. The company's LAMP-vax technology vaccines encode the expression of a fusion protein that includes the therapeutic antigen and the LAMP targeting protein. ITI is headquartered in Rockville......
$250

Crescendo Biologics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company s pipeline includes humabody programs targeting oncology. It specializes in the antibody discoveries and development that include CAT, medimmune, morphosys and GSK. Crescendo develops a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The company's oncology programmes produce high value, novel therapeutics that capitalizes on advantages of the Humabody VH format. Crescendo is headquartered in Cambridge, the UK. Crescendo Biologics Ltd - Pharmaceuticals & Healthcare - Deals and Allia......
$250

Institut Curie – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, genetics and carcinogenesis, cell and tissue imaging, and others. It provides care, research and training services for detecting, treating and monitoring cancer. Institut Curie offers services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain, medical imaging, and others. The foundation provides masters, PhD and postdoctoral fellowship programmes and other courses. Institut Curie is headquartered in Paris, France. Institut Curie ......
$250

Zavante Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investigational first-in-class injectable epoxide antibiotic. Zavante's ZOLYD is being developed for the treatment of infectious diseases such as complicated urinary tract infections, acute bacterial skin and skin structure infections, and others. The company works in collaboration with private and public firms to conduct its research and development activities. Zavante is headquartered in San Diego, California, the US. Zavante Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances......
$250

Tenet Healthcare Corp (THC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, with a comprehensive healthcare delivery network. The company serves urban and rural communities in US through general hospitals, including children's hospitals, specialty hospitals, academic medical centers and critical access hospitals. Tenet's subsidiaries provide healthcare services through several free-standing and provider-based diagnostic imaging centers, free-standing emergency department, urgent care centers and ambulatory surgery centers. It also operates private hospitals and clinics......
$250

PsiOxus Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PsiOxus Therapeutics Ltd (PsiOxus), formerly known as Myotec Therapeutics Ltd, is a drug company that develops novel therapeutics for cancer and other clinically unmet diseases. The company's pipeline product portfolio includes an oncolytic vaccine and a dual action anabolic catabolic transforming agent. It also has an antibody armed oncolytic platform under development. PsiOxus's products find application in the treatment of various cancer diseases such as cachexia, sarcopenia, metastatic cancer, and solid tumours, among others. It holds expertise in enhancing the therapeutic potency, safety and delivery kinetics through genetic modification to produce cancer vaccines. PsiOxus is headquartered in Abingdon, the UK. PsiOxus Therapeutics Ltd - Pharmaceuticals & Healthcare - Dea......
$250

Mission Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mission Therapeutics Ltd (Mission) is a drug discovery company that develops small molecule drugs targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company's USP30 is the DUB that localizes to the outer mitochondrial membrane. Its USP7 is a DUB with oncology links and an anti-cancer target. Mission's DUB programmes also include a number of other DUB targets in oncology such as DNA damage response and synthetic lethal mechanisms, neurodegeneration and inflammation. The company receives grants to support the discovery and preclinical development of inhibitors directed against a specific DUB. Mission is headquartered in Cambridge, the UK. Mission Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you......
$250